| Catalog_no |
ADMC0949 |
| Product_name |
AZD-3759 |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
880.00/1660.00/2660.00 |
| Specificity |
Target: EGFR . Fields: AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. IC50: 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Dilution |
IC50: 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Purification |
>98% |
| Concentration |
靶点：EGFR;IC50： 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
AZD-3759,AZD 3759,,AZD3759 |
| Molecular Weight |
459.14 |
| Notes |
AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. IC50: 0.3 nM (EGFRwt), 0.2 nM (EGFRL858R), 0.2 nM (EGFRexon 19Del)[1] |
| Instructions |
 查看与下载 |
